MA
SANA icon

Modus Advisors’s Sana Biotechnology SANA Stock Holding History

Modus Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-55,000
Closed -$158K – 123
2026
Q1 		$158K Hold
55,000
– – 0.04% 113
2025
Q4 		$224K Buy
+55,000
New +$246K 0.06% 112

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Modus Advisors's SANA Position: Q2 2026 in Review

Modus Advisors sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 55,000 shares — an estimated $158K sold.

Modus Advisors first reported a position in SANA in Q4 2025 and held it in 2 quarters. The position peaked at $224K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Modus Advisors reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Modus Advisors sold 55,000 Sana Biotechnology shares in Q2 2026, an estimated $158K.
  • Modus Advisors first reported a position in Sana Biotechnology in Q4 2025 and held it in 2 quarters.
  • Modus Advisors's Sana Biotechnology position peaked at $224K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Modus Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.